Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design, Synthesis, and Biological Activity of New CB2 Receptor Ligands: from Orthosteric and Allosteric Modulators to Dualsteric/Bitopic Ligands
Francesca Gado, Rebecca Ferrisi, Beatrice Polini, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 14, pp. 9918-9938
Open Access | Times Cited: 22

Showing 22 citing articles:

Functional dynamics of G protein-coupled receptors reveal new routes for drug discovery
Paolo Conflitti, Edward Lyman, Mark S.P. Sansom, et al.
Nature Reviews Drug Discovery (2025)
Closed Access | Times Cited: 3
New strategies to enhance the efficiency and precision of drug discovery
Qi An, Liang Huang, Chuan Wang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access | Times Cited: 1
The Skin and Natural Cannabinoids–Topical and Transdermal Applications
Silviu-Iulian Filipiuc, Anca-Narcisa Neagu, Cristina Mariana Urîtu, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 7, pp. 1049-1049
Open Access | Times Cited: 19
Click chemistry-aided drug discovery: A retrospective and prospective outlook
Rui Zhao, Junlong Zhu, Xiaoying Jiang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 116037-116037
Closed Access | Times Cited: 13
A Proteomic Approach Identified TFEB as a Key Player in the Protective Action of Novel CB2R Bitopic Ligand FD22a against the Deleterious Effects Induced by β-Amyloid in Glial Cells
Beatrice Polini, Lorenzo Zallocco, Francesca Gado, et al.
Cells (2024) Vol. 13, Iss. 10, pp. 875-875
Open Access | Times Cited: 5
T1AM/TAAR1 System Reduces Inflammatory Response and β-Amyloid Toxicity in Human Microglial HMC3 Cell Line
Beatrice Polini, Caterina Ricardi, A Bertolini, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11569-11569
Open Access | Times Cited: 11
Novel Orthosteric/Allosteric Ligands of Cannabinoid Receptors: An Unexpected Pharmacological Profile
Rebecca Ferrisi, Beatrice Polini, Anna Maria Smolyakova, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Identification of a Cannabinoid Receptor 2 Allosteric Site Using Computational Modeling and Pharmacological Analysis
Zara Farooq, Pietro Delre, Stylianos Iliadis, et al.
ACS Pharmacology & Translational Science (2025)
Open Access
Designing drugs and chemical probes with the dualsteric approach
Jinyin Zha, Jixiao He, Chengwei Wu, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 24, pp. 8651-8677
Closed Access | Times Cited: 9
Targeting the endocannabinoid system: Structural determinants and molecular mechanism of allosteric modulation
Jiayi Yuan, Bo Ram Yang, Guanyu Hou, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 7, pp. 103615-103615
Open Access | Times Cited: 8
Design, synthesis and biological evaluation of novel orthosteric-allosteric ligands of the cannabinoid receptor type 2 (CB2R)
Rebecca Ferrisi, Francesca Gado, Beatrice Polini, et al.
Frontiers in Chemistry (2022) Vol. 10
Open Access | Times Cited: 13
New Insights into Bitopic Orthosteric/Allosteric Ligands of Cannabinoid Receptor Type 2
Rebecca Ferrisi, Beatrice Polini, Caterina Ricardi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2135-2135
Open Access | Times Cited: 7
Discovery of 4-(1,2,4-Oxadiazol-5-yl)azepan-2-one Derivatives as a New Class of Cannabinoid Type 2 Receptor Agonists for the Treatment of Inflammatory Pain
Jinshan Nan, Jingming Liu, Guifeng Lin, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 5, pp. 3460-3483
Closed Access | Times Cited: 7
Novel Cannabinoid Receptor 2 (CB2) Low Lipophilicity Agonists Produce Distinct cAMP and Arrestin Signalling Kinetics without Bias
Raahul Sharma, Sameek Singh, Zak M. Whiting, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6406-6406
Open Access | Times Cited: 5
The Interplay between Cannabinoid Receptors and Microglia in the Pathophysiology of Alzheimer’s Disease
Rebecca Ferrisi, Francesca Gado, Caterina Ricardi, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 23, pp. 7201-7201
Open Access | Times Cited: 5
Bridging the Binding Sites: Dualsteric Ligands for the Cannabinoid 2 Receptor (CB2R)
Anna Tutov, Sophie A. M. Steinmüller, Yesid A. Ramírez, et al.
Advanced Therapeutics (2023) Vol. 6, Iss. 4
Open Access | Times Cited: 4
Cannabinoid type-2 receptors: An emerging target for regulating schizophrenia-relevant brain circuits
Anthony S. Ferranti, Daniel J. Foster
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 6
Bridging the Binding Sites 2.0: Photoswitchable Dualsteric Ligands for the Cannabinoid 2 Receptor
Sophie A. M. Steinmüller, Anna Tutov, James N. Hislop, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 20, pp. 3737-3744
Closed Access | Times Cited: 3
Mechanisms Underlining Inflammatory Pain Sensitivity in Mice Selected for High and Low Stress-Induced Analgesia—The Role of Endocannabinoids and Microglia
Piotr Poznański, Joanna Giebułtowicz, Justyna Durdzinska, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11686-11686
Open Access | Times Cited: 4
Development and evaluation of deuterated [18F]JHU94620 isotopologues for the non-invasive assessment of the cannabinoid type 2 receptor in brain
Daniel Gündel, Mudasir Maqbool, Rodrigo Teodoro, et al.
EJNMMI Radiopharmacy and Chemistry (2024) Vol. 9, Iss. 1
Open Access
3-Iodothyronamine (T1AM) Reduces Inflammatory Response in Human Microglial HMC3 Cell Line
Beatrice Polini, Caterina Ricardi, A Bertolini, et al.
(2023)
Open Access | Times Cited: 1
Design and Synthesis of Novel 1‐((1‐Phenyl‐1H‐1,2,3‐triazol‐4‐yl)methyl)pyridin‐2(1H)‐one Derivatives
Selbi Keskin
ChemistrySelect (2023) Vol. 8, Iss. 32
Closed Access
Page 1

Scroll to top